Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Interest & Investment Income (2016 - 2019)

Historic Interest & Investment Income for Tg Therapeutics (TGTX) over the last 4 years, with Q2 2019 value amounting to $1.1 million.

  • Tg Therapeutics' Interest & Investment Income rose 38295.96% to $1.1 million in Q2 2019 from the same period last year, while for Jun 2019 it was $1.8 million, marking a year-over-year increase of 20864.2%. This contributed to the annual value of $857000.0 for FY2018, which is 19050.85% up from last year.
  • Latest data reveals that Tg Therapeutics reported Interest & Investment Income of $1.1 million as of Q2 2019, which was up 38295.96% from $149000.0 recorded in Q1 2019.
  • In the past 5 years, Tg Therapeutics' Interest & Investment Income ranged from a high of $1.1 million in Q2 2019 and a low of $50000.0 during Q2 2017
  • Over the past 4 years, Tg Therapeutics' median Interest & Investment Income value was $121000.0 (recorded in 2017), while the average stood at $206923.1.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 4602.12% in 2017, then soared by 38295.96% in 2019.
  • Tg Therapeutics' Interest & Investment Income (Quarter) stood at $57544.0 in 2016, then soared by 110.27% to $121000.0 in 2017, then soared by 119.83% to $266000.0 in 2018, then surged by 304.89% to $1.1 million in 2019.
  • Its last three reported values are $1.1 million in Q2 2019, $149000.0 for Q1 2019, and $266000.0 during Q4 2018.